NCT04724083View on ClinicalTrials.gov

Inflammatory Pathways and Cardiac Growth Factors Associated With Fabry Disease Cardiomyopathy

UnknownOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

December 1, 2020

Primary Completion Date

May 1, 2022

Study Completion Date

August 1, 2022

Conditions
Fabry
Interventions
DIAGNOSTIC_TEST

biomarkers

new diagnostic biomarkers

Trial Locations (1)

22030

RECRUITING

Lysosomal and Rare disorder research and treatment center, Fairfax

Sponsors

Collaborators (1)

Sanofi
All Listed Sponsors
collaborator

Sanofi

INDUSTRY

lead

Lysosomal and Rare Disorders Research and Treatment Center, Inc.

OTHER